Ampac Fine Chemicals

Published: 16-Aug-2007
Ingredients

Stand no: 9A96

Stand no: 9A96

Ampac Fine Chemicals is a technology-focused cGMP custom manufacturer of APIs and registered intermediates based in Sacramento, California.

We provide, at one site, process development and engineering, scale-up and cGMP manufacturing from kilogram to multi-tons using unique technologies.

We specialise in manufacturing of highly potent compounds (HPAPIs), handling of hazardous and energetic materials, continuous processing and continuous chromatography (SMB).

We provide our customers with economical solutions to challenging problems using a blend of unique technology and expertise in process development and engineering developed over the past 50 years.

  • Companies:
  • AMPAC Fine Chemicals
See more

You may also like

Ingredients

AMPAC registered as manufacturer of controlled substances

Read more
Plant upgrades extend capabilities at California facility

Trending Articles

  1. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  2. Carbosynth Limited
  3. Highly potent APIs: Hazards in classification and handling This variability and subjective nature of classification means that the OEL is best considered as a tool for site risk management teams
  4. Shasun Chemicals and Drugs Limited
  5. Innovative new process used to produce a diabetes and weight loss drug Camilla Koller, Marketing Communications Associate, tells Dr Kevin Robinson how Bachem has used its extensive experience and expertise in peptide synthesis to develop a fully synthetic method of producing liraglutide at an industrial scale

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Ingredients

AMPAC registered as manufacturer of controlled substances

Plant upgrades extend capabilities at California facility
Manufacturing

AMPAC to produce smallpox drug API for Chimerix

Will be manufactured in a remotely operated process plant
Ingredients

AMPAC Fine Chemicals expands production with plant in Texas

The addition of these facilities increases the firm’s total reactor capacity by approximately 30%
Manufacturing

Codexis partners Dishman and AMPAC Fine Chemicals

Codexis, a Californian biotechnology firm, has formed two separate pharmaceutical manufacturing partnerships with Dishman Pharmaceuticals and Chemicals and AMPAC Fine Chemicals (AFC), a subsidiary of American Pacific Corporation.
Manufacturing

CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery

The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
Ingredients

Therapeutic: acoramidis for transthyretin amyloid cardiomyopathy

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a rare progressive disease that results from genetic mutations or ageing; misfolded TTR protein accumulates as amyloid fibrils in the myocardium
Ingredients

Therapeutic: lutikizumab for hidradenitis suppurativa

Hidradenitis suppurativa (HS) — also known as acne inversa — is a chronic, recurrent and progressive inflammatory disease that leads to irreversible skin damage and disability
Subscribe now